ERBB2 and breast cancer: As presented in Fig. 4a, b, T-DM1 treatment alone induced significant cellular apoptosis in both HER2-positive breast cancer cells, whereas combinational treatment of T-DM1 and CQ drastically reduced T-DM1-medicated apoptotic cell death.